By Editor , 3 November 2026 Cambiotics Enrolls First Patient in 70-Firefighter PFAS Probiotic Trial Copenhagen – November 03, 2026 -- Cambiotics ApS has enrolled the first participant in its first human clinical trial, testing whether its probiotic strain 46-SL1 changes serum PFAS concentrations in 70 firefighters with prior occupational exposure.